Healthcare

Techseriesinsight > Blog > News > Healthcare

April 8, 2025
PRNewswire
Healthcare

Blue Faery Recognizes Excellence in Liver Cancer Research

Blue Faery: The Adrienne Wilson Liver Cancer Association announces the Blue Faery Award (BFA) for Excellence in Liver Cancer Research recipient. Primary liver cancer, also known as Hepatocellular Carcinoma (HCC), remains the...

April 8, 2025
PRNewswire
Healthcare

Dr Crystal Mackall Receives IO360 Lifetime Achievement Award for Pioneering Work in T Cell Therapies

The Conference Forum announced that the Immuno-Oncology 360º (IO360º) Summit honored Crystal Mackall, MD, FAAP, FAACR, Stanford University, with the IO360º Lifetime Achievement Award for her scientific innovation, impact on drug development,...

April 8, 2025
PRNewswire
Healthcare

Alphyn Announces First Patient Dosed in CLEAR-AD1 Global Phase 2b Clinical Trial Program of Zabalafin Hydrogel for Atopic Dermatitis

Alphyn, a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics®, announced today that the first patient has been dosed in its CLEAR-AD1 Phase 2b clinical trial of Zabalafin Hydrogel in Australia. The trial will evaluate...

April 4, 2025
PRNewswire
Healthcare

CytoSorbents Extends Expiration Date of Outstanding Series B Right Warrants

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announced the extension of the expiration date of...

April 4, 2025
PRNewswire
Healthcare

New Rice University institute to study lifetime health impacts and develop targeted interventions

Rice University has launched the Institute of Health Resilience and Innovation (IHRI), a pioneering research initiative dedicated to understanding the lifetime impacts of health stressors and developing targeted interventions to...

April 3, 2025
PRNewswire
Healthcare

Lumen Bioscience’s LMN-201 Achieves 100% Initial C. difficile Clinical Cure in Preliminary Cohort of RePreve Trial

In a landmark achievement for its pioneering spirulina-based drug development platform, Lumen announced today top-line results from the sentinel cohort of its RePreve Clinical Trial evaluating LMN-201 for Clostridioides difficile infection (CDI). LMN-201...

April 3, 2025
PRNewswire
Healthcare

TopGum Closes Acquisition of Island Abbey Nutritionals

Gummy supplement specialist TopGum Industries, Ltd. (TASE: TPGM), announced today that it has completed the acquisition of Island Abbey Nutritionals™, a leading CDMO specializing in supplement gummies and lozenges, located in Prince...

April 2, 2025
PRNewswire
Healthcare

Quest Diagnostics Introduces HPV Specimen Self-Collection for Cervical Cancer Screening

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced a new solution aimed at broadening access to human papillomavirus (HPV) screening to help identify women who are...

April 1, 2025
PRNewswire
Healthcare

ixlayer and Ipsos’ “ixInsights 2025” Study Reveals Consumer Expectations for Digital Health and Pharma’s Role in Enhancing Patient Experience

ixlayer, a leading cloud-based healthtech platform, with Ipsos, a global leader in market research, have released findings from the inaugural research report, “ixlayer ixInsights 2025: Pharma’s Role in Improving the Health...

March 27, 2025
PRNewswire
Healthcare

Halifax Group Names Howard Miller as Operating Executive

Halifax Group (“Halifax”), a middle market private equity firm that partners with management to invest in market-leading companies, today announced that it has engaged Howard C. Miller as an Operating Executive....